VERACYTE, INC. APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition
VERACYTE, INC. (VCYT) reported APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition of $43.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-02.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition · last filed 2020-11-02
- VERACYTE, INC. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2020-09-30 was $43.00K, a 83.07% decline year-over-year.
- VERACYTE, INC. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2020-06-30 was $331.00K, a 87.01% increase year-over-year.
- VERACYTE, INC. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2019-09-30 was $254.00K.
- VERACYTE, INC. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2019-06-30 was $177.00K.
| Period end | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 9 month |
|---|---|---|---|
| 2020-09-30 | $43.00K 10-Q · filed 2020-11-02 | $374.00K derived: sum of 2 quarters · filed 2020-11-02 | $728.00K 10-Q · filed 2020-11-02 |
| 2020-06-30 | $331.00K 10-Q · filed 2020-07-30 | $685.00K 10-Q · filed 2020-07-30 | |
| 2019-09-30 | $254.00K 10-Q · filed 2020-11-02 | $431.00K derived: sum of 2 quarters · filed 2020-11-02 | $572.00K 10-Q · filed 2020-11-02 |
| 2019-06-30 | $177.00K 10-Q · filed 2020-07-30 | $318.00K 10-Q · filed 2020-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |